Searched for
SANOFI CONSUMER HEALTHCARE
Dividend alert! Last day to buy HDFC Bank, Tata Motors PV, 14 other stocks for dividends worth Rs 248Under SEBI's T+1 settlement cycle, investors must purchase a company's shares at least one trading day before the record date to ensure the...- Dividends and bonus issues: 31 stocks turning ex-record date this week. Do you own any?As many as 31 companies, including HDFC Bank, Tata group firms and Brigade Enterprises, will turn ex-record date for dividends and bonus is...
- Sunil Singhania-backed Abakkus Small Cap Fund first portfolio out since NFO; 42 stocks held, Karur Vysya Bank top betSunil Singhania backed Abakkus Mutual Fund has unveiled the maiden portfolio of its smallcap fund - Abakkus Small Cap Fund, following an in...
- Sanofi Consumer Healthcare shares zoom 14% after Q4 profit jumps 50%; declares dividend of Rs 75Sanofi Consumer Healthcare shares surged over 14% following a robust 50% year-on-year net profit increase to Rs 66.5 crore in Q4. Driven by...
- Sanofi Health leases office space in Hyderabad"The monthly rental is set at ?75 per sq ft, amounting to a total of ?2.05 crore. A security deposit equivalent to 7.5 months of rent, valu...
- CD&R makes Rs 2,983 cr open offer for 26% stake in Sanofi Consumer Healthcare IndiaGlobal investment firm CD&R announces an open offer to acquire a 26% stake in Sanofi Consumer Healthcare India for up to Rs 2,983 crore. Th...
- Mankind may end up spinning out a winner in consumer brands unitThe company entered the OTC business in 2007 and it has grown to have established brands such as Manforce, HealthOK, Prega News, AcneStar, ...
- Sanofi Consumer Healthcare lists on stock exchanges after demerger, shares hit 5% upper circuit on day 1Shares of Sanofi Consumer Healthcare India made their market debut on Friday, listing on both the NSE and BSE. On its first day of trading,...
- Sanofi India decides to put headquarters in Mumbai on the blockSanofi's Indian subsidiary is planning to sell its 150,000 sq ft standalone property in Mumbai's Powai area, which serves as its current he...
- CORONA remedies buys Sanofi India's ortho brand MyorilAhmedabad-based pharmaceutical company CORONA Remedies has acquired the muscle relaxant brand Myoril from Sanofi India for Rs234 crore. The...
- Sanofi reinvigorates India business, with eye on higher growthThe company has outlined an ‘India for India’ strategy, where it will focus on diabetes, consumer health, a combination of product innovati...
- Sanofi India board OKs demerger of consumer health businessDrug firm Sanofi India on Wednesday said its board has approved the demerger of its consumer healthcare business into a separate entity. Th...
- Sanofi board approves demerger of its consumer healthcare businessThis decision will open new gates for the India business and employees in a value-driven move to accelerate growth for both the pharmaceuti...
- French drugmaker Sanofi looks to spin off its consumer business in IndiaThe leading vaccine maker is working with Bank of America on the demerger process, said the people cited above. About 60% of Sanofi India i...
- Sanofi names Rodolfo Hrosz as India unit headHrosz will transition from being Sanofi’s general manager, Consumer Healthcare business in Brazil to his new role in India as soon as the a...
- Sanofi, Boehringer Ingelheim close business swap in IndiaSanofi is excited to embrace the incoming CHC brands and people associated with this business, as this is in line with objective of boostin...
- Sanofi India inks pact with NIPER KolkataAs per the pact, the company will provide opportunities of internship or project work to NIPER Kolkata MS/PhD students at manufacturing sit...
- Sanofi, Boehringer Ingelheim seek CCI nod for $25-billion global asset swap dealThe commission will review if the two companies swapping their businesses will cause any adverse impact on the local competition.
- Sanofi India to double consumer healthcare biz to Rs 1,000 crSanofi India (previously known as Aventis Pharma) today said it aims to double its consumer healthcare business in the next five years.
- Sanofi Aventis plans to buy Generics, OTC brandsIt was also believed to been in the fray to buy Actis' 63% stake in Paras Pharmaceuticals, that was eventually acquired by Reckitt Benckise...
Load More
